Brief: Kontafarma China Expects FY2025 Consolidated Net Loss Of HK$414.1 Million-HK$506.2 Million
11/03/2026 14:08
March 11 (Reuters) - Kontafarma China Holdings Ltd 1312.HK: EXPECTS FY2025 CONSOLIDATED NET LOSS OF HK$414.1 MILLION-HK$506.2 MILLION EXPECTED RESULT DUE TO HK$169.3 MILLION IMPAIRMENT LOSS ON FINANCIAL ASSETS IN FY2025, OTHERS Further company coverage: 1312.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr